Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a …
Industry Peers
Health Information Services| Headline | Source | Time |
|---|---|---|
Older | ||
 Omada Health (OMDA) Q2 2026 Earnings Call Transcript Revenue surged 43% to $88 million as margins expanded and guidance rose. | ||
 Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy Omada Health (NASDAQ:OMDA) highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen channel partnerships and use GLP-1-related demand to broaden customer relationships | ||
 Omada Health (OMDA) Could Be 4% Undervalued As Record Earnings Reset The Debate Omada Health (OMDA) drew investor attention on 6 August 2026 after reporting record second quarter results, raising full year 2026 guidance, and outlining a planned CEO transition effective 1 January 2027. See our latest analysis for Omada Health. At a latest share price of $23.67, Omada Health has seen a sharp shift in sentiment, with a 1 day share price return of 21.14% and 7 day share price return of 19.30% around the earnings beat and CEO succession news. That sits within a stronger... | ||
 Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. | ||
 Omada Health Q2 Earnings Call Highlights Omada Health (NASDAQ:OMDA) reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also announced that President Wei-Li Shao will succeed Co-founder and Chief Executiv | ||
Omada Health Inc (OMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability ... Omada Health Inc (OMDA) reports its strongest quarter ever with revenue up 43% year-over-year, achieving GAAP profitability and raising full-year 2026 guidance. | ||
 Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates Omada Health, Inc. (OMDA) delivered earnings and revenue surprises of +200.00% and +8.53%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 IPO Stock Of The Week: This Eli Lilly Partner Soars 118% In Three Months Omada, an Eli Lilly partner, has soared more than 118% in just a few months, moving up the right side of a new base. | ||